OMEGA THERAPEUTICS
Omega Therapeutics, Inc. is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines.
OMEGA THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.omegatherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
212-600-1902
Email Addresses:
[email protected]
Total Funding:
239.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Tune Therapeutics
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
LifeSci Venture Partners
LifeSci Venture Partners investment in Series C - Omega Therapeutics
Invus
Invus investment in Series C - Omega Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Omega Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series C - Omega Therapeutics
Point72
Point72 investment in Series C - Omega Therapeutics
Logos Capital
Logos Capital investment in Series C - Omega Therapeutics
Cowen and Company
Cowen and Company investment in Series C - Omega Therapeutics
BlackRock
BlackRock investment in Series C - Omega Therapeutics
Mirae Asset Capital
Mirae Asset Capital investment in Series C - Omega Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series B - Omega Therapeutics
Key Employee Changes
Official Site Inspections
http://www.omegatherapeutics.com Semrush global rank: 4.65 M Semrush visits lastest month: 2.11 K
- Host name: 66-135-26-141.constant.com
- IP address: 66.135.26.141
- Location: Lehi United States
- Latitude: 40.3942
- Longitude: -111.8483
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84043
More informations about "Omega Therapeutics"
Mission and Values | The Omega Therapeutics ethos
Being credible and transparent to patients, shareholders, partners, and most importantly, ourselves, is key to having confidence in our organization and succeeding in our mission. Innovation We are dedicated to developing a …See details»
Omega Therapeutics Reports First Quarter 2024 Financial Results …
May 6, 2024 For more information, visit omegatherapeutics.com, or follow us on X and LinkedIn. About the OMEGA Platform The OMEGA platform leverages the Company’s deep …See details»
Omega Therapeutics - Crunchbase Company Profile
Omega Therapeutics offers a proprietary epigenomic programming platform. Omega Therapeutics may be growing as evidenced by a significant deal with Novo Nordisk, which is a strong indicator of corporate partnership and …See details»
Omega Therapeutics - LinkedIn
Omega Therapeutics is a clinical-stage biotechnology company pioneering the first systematic approach of using mRNA as programmable epigenomic medicines.See details»
Omega Therapeutics Presents New Preclinical Data Supporting the ...
Oct 16, 2023 For more information, visit omegatherapeutics.com, or follow us on X (formerly Twitter) and LinkedIn. Forward-Looking Statements This press release contains forward …See details»
Omega Therapeutics Appoints Chris Schade to its Board of Directors
Jul 12, 2023 Accomplished Industry Veteran Brings Deep Strategic and Operational Expertise. CAMBRIDGE, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. …See details»
Epigenomic Programming | The story behind Omega …
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. You can allow the use of all cookies by clicking “Accept All”.If you would like to refuse all non-essential …See details»
Patient resources and clinical trials | Omega Therapeutics
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. You can allow the use of all cookies by clicking “Accept All”.If …See details»
Omega Therapeutics - Craft
Oct 29, 2024 Omega Therapeutics has 1 employees at their 1 location and $3.09 m in annual revenue in FY 2023. See insights on Omega Therapeutics including office locations, …See details»
Omega Therapeutics to Advance Pipeline and Platform …
Mar 30, 2021 For more information, visit omegatherapeutics.com, or follow us on Twitter and LinkedIn. Investor contact: Joseph Rayne Argot Partners 212.600.1902 [email protected] …See details»
Omega Therapeutics, Inc. (OMGA) - Yahoo Finance
Find the latest Omega Therapeutics, Inc. (OMGA) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Pre-transcriptional control | Omega Therapeutics platform
Our foundational knowledge of the role of insulated genomic domains (IGDs) in gene expression and the implications of their regulation in healthy and diseased states has enabled us to curate …See details»
Omega Therapeutics Announces Clinical Supply Agreement to …
CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the …See details»
Omega Therapeutics Presents New Preclinical Data at AACR 2024 ...
Apr 9, 2024 MYC-directed epigenomic controller exerts anti-tumor effect in preclinical models of EGFR inhibitor-resistant NSCLC regardless of underlying resistance mechanismValidation of …See details»
Pipeline overview | Omega Therapeutics development candidates
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. You can allow the use of all cookies by clicking “Accept All”.If …See details»
Omega Therapeutics Presents New Preclinical Data at AACR 2024 ...
Apr 9, 2024 For more information, visit omegatherapeutics.com, or follow us on X and LinkedIn. Forward-Looking Statements Securities Litigation Reform Act of 1995. All statements …See details»
Omega Therapeutics Presents New Preclinical Data - GlobeNewswire
May 31, 2023 MYC-targeting Omega Epigenomic Controllers (OECs) Demonstrated Consistent Anti-Tumor Activity Across Multiple Tumor Types, Including Hepatocellular...See details»
SCIENCE Foundational Science - OMEGA Therapeutics
Epigenetics is nature’s fundamental mechanism for gene control and cell differentiation. Through the pioneering research of our founding scientific advisors and our own work, we have …See details»
Omega Therapeutics Reports Fourth Quarter and Full Year 2022 …
Dec 31, 2022 For more information, visit omegatherapeutics.com, or follow us on Twitter and LinkedIn. Forward-Looking Statements. This press release contains forward-looking …See details»